Jackie Hunter

Board Director, Benevolent AI and CEO

BenevolentBio

Professor Jackie Hunter CBE is a Board Director for Benevolent AI, a British held AI company which is using
AI to augment the research capabilities of drug scientists, radically changing the way R&D is done. She joined the company with over thirty years of experience in the bioscience research sector, working across academia and industry including leading neurology and gastrointestinal drug discovery and early clinical development for GlaxoSmithKline. She was awarded a CBE in the Queen’s Birthday Honours list for Services to the Pharmaceutical Industry and was recognized by Forbes Magazine as one of the top 20 Women Advancing AI Research. She is a member of the Biomedical Board for A*Star in Singapore and the Science Advisory Board for the Data Science Institute at Imperial College. She is also a visiting Professor at Imperial College and at St Georges Hospital Medical School.